Insmed News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.01.17	Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP... (PR Newswire)
05.10.16	Insmed Signs License Agreement With AstraZeneca For Oral DPP I (RTTNews)
09.06.16	FDA Panel Nod For PFE, INSM Withdraws MAA, FCSC's Voice Fades Out (RTTNews)
06.05.16	Do You Have Any Of These Rare Disease Biotech Stocks In Your Portfolio? (RTTNews)
16.02.15	Did You Make The Most Of These Secondary Offerings? (RTTNews)
30.12.13	What Made These Stocks Winners In 2013? (RTTNews)
21.10.13	Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros (PR Newswire)
15.10.13	Insmed Announces The Completion Of Patient Enrollment In ARIKACE Phase 2 Study (RTTNews)
20.09.13	Did You Buy These Stocks? (RTTNews)
03.09.13	Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA (PR Newswire)
17.07.13	Insmed Prices Public Offering Of 6.0 Mln Shares At $10.40/shr (RTTNews)
10.07.08	Wall Street Media Presents Exclusive Videos from the Collins Stewart Fourth Annual Growth Conference and the T. Boone Pickens Press Conference (Businesswire)
02.08.07	Insmed Reports Financial Results for Second Quarter and First Half of 2007 (Businesswire)
25.07.07	Insmed Announces Second Quarter and First Half Earnings Release Date and Conference Call (Businesswire)
30.04.07	Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study (Businesswire)
03.11.06	Insmed Incorporated Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2006 (Businesswire)
05.07.06	Court Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at Trial (Businesswire)
22.06.06	Insmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; Company Also to Present Data on the Unique Pharmacokinetics of IPLEX (Businesswire)
09.06.06	Insmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and Pricing (Businesswire)
12.05.06	Insmed Incorporated to Present at the Rodman & Renshaw 3rd Annual Healthcare Conference (Businesswire)
02.03.06	Insmed Incorporated Reports Financial Results for the Fourth Quarter and Twelve-Months of 2005 (Businesswire)
29.09.05	Insmed Provides Update on iPlex Pivotal Trial Data in Severe Primary IGF-1 Deficiency (Businesswire)
29.09.05	Insmed Issues Statement Regarding IPLEX(TM) Approvable Letter Press Release (Businesswire)
15.03.05	Insmed Announces Completion of $35 Million Financing (Businesswire)
22.02.05	Insmed Provides Response to United States Patent Lawsuit; Seeks Immedi (Businesswire)
16.02.05	Insmed Provides Response to UK Patent Lawsuit (Businesswire)
03.01.05	Insmed Submits New Drug Application -NDA- to Seek Regulatory Approval (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Insmed Inc.

Aktien Top/Flop

Meistgelesene Nachrichten